Source:http://linkedlifedata.com/resource/pubmed/id/11894812
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-3-14
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1528-4336
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
89-98
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:11894812-Anti-HIV Agents,
pubmed-meshheading:11894812-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:11894812-HIV Infections,
pubmed-meshheading:11894812-Humans,
pubmed-meshheading:11894812-Lipodystrophy,
pubmed-meshheading:11894812-Metabolic Diseases,
pubmed-meshheading:11894812-Protease Inhibitors
|
pubmed:articleTitle |
HIV-associated lipodystrophy, metabolic complications, and antiretroviral toxicities.
|
pubmed:affiliation |
Chelsea and Westminster Hospital, London, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Review
|